USFDA5 Nov 2025, 11:21 am
Zydus Lifesciences Ltd Receives EIR for SEZ II Manufacturing Facility in Ahmedabad
AI Summary
Zydus Lifesciences Ltd has announced that it has received an Establishment Inspection Report (EIR) for its manufacturing plant located in SEZ — II, Ahmedabad. The USFDA conducted a Pre-Approval Inspection (PAI) from 11th to 14th August 2025, which concluded with NIL observations. The facility has been classified as No Action Indicated (NAI). This disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Zydus Lifesciences Ltd has received an EIR for its manufacturing plant in SEZ — II, Ahmedabad
- The USFDA conducted a PAI from 11th to 14th August 2025 with NIL observations
- The facility has been classified as No Action Indicated (NAI)
- This disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015